Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberte Aubert

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical, Cosmetic and Investigational Dermatology|May 23, 2020
Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with PsoriasisKhaled Ezzedine, Anne Claire Fougerousse, Roberte Aubert, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 2010
Hyperadiponectinemia is independent of kidney function, diabetes duration, and control in type 1 diabetic patients without microangiopathyCharbel Abi Khalil, Kamel Mohammedi, Roberte Aubert, et al.
Diabetes|March 30, 2004
Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective studyFrédéric Fumeron, Roberte Aubert, Afshan Siddiq, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 17, 2022
Prevalence of visible skin diseases: An international study of 13,138 peopleBernard Cribier, Marketa Saint Aroman, Stéphanie Merhand, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 20, 2010
Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetesRiphed Jaziri, Roberte Aubert, Ronan Roussel, et al.
Diabetes|March 29, 2006
The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) studyRiphed Jaziri, Stephane Lobbens, Roberte Aubert, et al.
Obesity (Silver Spring, Md.)|December 5, 2009
Adiponectin multimers and ADIPOQ T45G in coronary artery disease in Caribbean type 2 diabetic subjects of African descentLydia Foucan, Nabila Ezourhi, Suliya Maimaitiming, et al.
Journal of Hypertension|April 22, 2010
Association of common variants in NPPA and NPPB with blood pressure does not translate into kidney damage in a general population studySuliya Maimaitiming, Ronan Roussel, Samy Hadjadj, et al.
Journal of Diabetes Investigation|May 21, 2014
Adiponectin gene variants, adiponectin isoforms and cardiometabolic risk in type 2 diabetic patientsLydia Foucan, Suliya Maimaitiming, Laurent Larifla, et al.
American Journal of Clinical Dermatology|February 21, 2021
Use of Complementary and Alternative Medicines by Patients with Psoriasis: Results from a Study with 2562 PatientsLaurent Misery, Jason Shourick, Julien Sénéschal, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical, Cosmetic and Investigational Dermatology|May 23, 2020
Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with PsoriasisKhaled Ezzedine, Anne Claire Fougerousse, Roberte Aubert, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 2010
Hyperadiponectinemia is independent of kidney function, diabetes duration, and control in type 1 diabetic patients without microangiopathyCharbel Abi Khalil, Kamel Mohammedi, Roberte Aubert, et al.
Diabetes|March 30, 2004
Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective studyFrédéric Fumeron, Roberte Aubert, Afshan Siddiq, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 17, 2022
Prevalence of visible skin diseases: An international study of 13,138 peopleBernard Cribier, Marketa Saint Aroman, Stéphanie Merhand, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 20, 2010
Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetesRiphed Jaziri, Roberte Aubert, Ronan Roussel, et al.
Diabetes|March 29, 2006
The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) studyRiphed Jaziri, Stephane Lobbens, Roberte Aubert, et al.
Obesity (Silver Spring, Md.)|December 5, 2009
Adiponectin multimers and ADIPOQ T45G in coronary artery disease in Caribbean type 2 diabetic subjects of African descentLydia Foucan, Nabila Ezourhi, Suliya Maimaitiming, et al.
Journal of Hypertension|April 22, 2010
Association of common variants in NPPA and NPPB with blood pressure does not translate into kidney damage in a general population studySuliya Maimaitiming, Ronan Roussel, Samy Hadjadj, et al.
Journal of Diabetes Investigation|May 21, 2014
Adiponectin gene variants, adiponectin isoforms and cardiometabolic risk in type 2 diabetic patientsLydia Foucan, Suliya Maimaitiming, Laurent Larifla, et al.
American Journal of Clinical Dermatology|February 21, 2021
Use of Complementary and Alternative Medicines by Patients with Psoriasis: Results from a Study with 2562 PatientsLaurent Misery, Jason Shourick, Julien Sénéschal, et al.
Pageof 3